| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent trends indicate a strong movement towards expanding product offerings within the healthcare sector, particularly with Eli Lilly's weight loss drug now being featured by other companies, such as Hims. Furthermore, innovative drug development remains a key focus, especially in addressing weight-loss and diabetes treatments, which heightens the company's competitive edge. These themes reflect a dynamic approach to meeting market demands and advancing pharmaceutical solutions. Overall, the emphasis on growth through expansion and innovation signals a positive outlook for product and service development. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.4 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.4 on 2025-04-11. The forces of Sentiment towards Fundamentals (-1.3), and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-10 | 0%(0%) | 0 | 0% | -0.4 | -1.5 | -1 | |||||||
| 2025-04-09 | 0%(0%) | 0 | 0% | -0.6 | -2.4 | -1 | |||||||
| 2025-04-08 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-07 | 0%(0%) | 0 | 0% | -0.6 | -2.4 | -1 | |||||||
| 2025-04-04 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-03 | 0%(0%) | 0 | 0% | -0.3 | -0.6 | -1 | |||||||
| 2025-04-02 | 0%(0%) | 0 | 0% | -0.3 | -0.7 | -1 | |||||||
| 2025-04-01 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-03-31 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:08:12 How regulatory measures, including tariffs, are affecting the pharmaceutical industry and its stakeholders. |
| 2025-05-19 17:08:12 The debate on whether tariffs are successfully encouraging companies to invest in U.S. manufacturing. |
| 2025-05-19 17:08:12 A positive trend indicating major pharma investment in domestic production, signaling a shift in industry strategy. |
| 2025-05-19 17:08:12 Concerns about how tariffs could disrupt the pharmaceutical supply chain, leading to shortages of critical medications. |
| 2025-05-19 17:08:12 The potential increase in drug prices due to tariffs on imported pharmaceuticals, affecting patients and healthcare access. |